The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.
Alex Cruz
No relevant relationships to disclose
Dung-Tsa Chen
No relevant relationships to disclose
William J. Fulp
No relevant relationships to disclose
Michael Chuong
No relevant relationships to disclose
Sarah Hoffe
No relevant relationships to disclose
Ravi Shridhar
No relevant relationships to disclose
Nikhil G Rao
No relevant relationships to disclose
Pamela Joy Hodul
No relevant relationships to disclose
Mokenge Peter Malafa
No relevant relationships to disclose
Nicholas Figura
No relevant relationships to disclose
Edward Eikman
No relevant relationships to disclose
Gregory M. Springett
No relevant relationships to disclose